Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/CSL stock hub

ASX/CSL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ASX/CSLis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
58.2B
Australian Securities Exchange
Market data

Live price

Current market quote for this ticker.

Current price
ASX/CSL
In the news

Latest news · ASX/CSL

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.2
P25 12.9P50 20.4P75 41.2
Trailing P/E28
P25 14.2P50 19.2P75 35.1
ROE6.7
P25 -118.7P50 -49.4P75 -1.2
ROIC11.5
P25 -74.7P50 -33.5P75 0.1
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ASX/CSL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
246
Groups with data
11
Currency
USD
Showing 246 of 246 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Australia
Country code
AU
Employees
29,904
Employees Change
-2,794%
Employees Change Percent
-8.54
Enterprise value
AUD 75.9B
Exchange
Australian Securities Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biotechnology
Isin
AU000000CSL8
Last refreshed
2026-05-10
Market cap
AUD 58.2B
Price
AUD 120
Price currency
AUD
Rev Per Employee
772,410.86x
Sector
Healthcare
Sic
2836
Symbol
asx/CSL
Website
https://www.csl.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
3.6%
EV Earnings
36.25x
EV/EBIT
12.59x
EV/EBITDA
10.23x
EV/FCF
16.59x
EV/Sales
3.28x
FCF yield
7.86%
Forward P/E
12.21x
P/B ratio
1.9x
P/E ratio
27.95x
P/S ratio
2.52x
PE Ratio10 Y
37.13x
PE Ratio3 Y
31.08x
PE Ratio5 Y
32.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

26
MetricValue
EBIT Margin
26.08%
EBITDA Margin
31.41%
FCF margin
19.8%
Gross margin
51.87%
Gross Profit
AUD 12B
Gross Profit Growth
-1.08%
Gross Profit Growth Q
-1.91%
Gross Profit Growth3 Y
1.23%
Gross Profit Growth5 Y
2.7%
Net Income
AUD 2.1B
Net Income Growth
-49.2%
Net Income Growth Q
-80.02%
Net Income Growth Years
2%
Net Income Growth3 Y
-19.16%
Net Income Growth5 Y
-8.65%
Pretax Margin
10.15%
Profit Margin
9.06%
Profit Per Employee
AUD 69,987
Profitable Years
30
ROA
6.58
Roa5y
7.85
ROCE
12.07
ROE
6.66
Roe5y
19.06
ROIC
11.52
Roic5y
15.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

29
MetricValue
Cagr10y
2.34%
Cagr15y
10.34%
Cagr1y
-49.47%
Cagr20y
11.24%
Cagr3y
-25.11%
Cagr5y
-13.98%
Div CAGR10
9.53%
Div CAGR3
8.03%
Div CAGR5
8.61%
EPS Growth
-49.48
EPS Growth Q
-80.15
EPS Growth Years
1
EPS Growth3 Y
-19.33
EPS Growth5 Y
-8.78
FCF Growth
38.39%
FCF Growth Q
14.19%
FCF Growth3 Y
16.74%
FCF Growth5 Y
17.31%
OCF Growth
22%
OCF Growth Q
3.42%
OCF Growth10 Y
0.09%
OCF Growth3 Y
9.25%
OCF Growth5 Y
6.74%
Revenue Growth
1.16x
Revenue Growth Q
-1.78x
Revenue Growth Quarters
2x
Revenue Growth Years
24x
Revenue Growth3 Y
1.35x
Revenue Growth5 Y
2.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
AUD 0.4
Assets
AUD 56.8B
Cash
AUD 1.7B
Current Assets
AUD 16.3B
Current Liabilities
AUD 6.4B
Debt
AUD 16.7B
Debt EBITDA
AUD 2.25
Debt Equity
AUD 0.54
Debt FCF
AUD 3.65
Equity
AUD 30.7B
Interest Coverage
9.54
Liabilities
AUD 26.1B
Long Term Assets
AUD 40.5B
Long Term Liabilities
AUD 19.8B
Net Cash
AUD -15B
Net Cash By Market Cap
AUD -25.75
Net Debt EBITDA
AUD 2.06
Net Debt Equity
AUD 0.49
Net Debt FCF
AUD 3.28
Tangible Book Value
AUD 5.3B
Tangible Book Value Per Share
AUD 11.05
WACC
4.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.57
Inventory Turnover
1.17
Net Working Capital
AUD 10.2B
Quick ratio
1.15
Working Capital
AUD 10.9B
Working Capital Turnover
AUD 3.7

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-0.1%
Dividend Growth
0.35%
Dividend Growth Years
4%
Dividend per share
AUD 4.03
Dividend Years
33
Dividend Yield
3.36%
Ex Div Date
2026-03-10
Last Dividend
AUD 1.81
Payout Frequency
Semi-Annual
Payout Ratio
101.5%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
26.01%
1Y total return
-49.45%
200-day SMA
181.9
3Y total return
-58%
50-day SMA
137.2
50-day SMA vs 200-day SMA
50under200
5Y total return
-52.91%
All Time High
342.8
All Time High Change
-65.02%
All Time High Date
2020-02-20
All Time Low
0.77
All Time Low Change
15,468.83%
All Time Low Date
1994-06-21
ATR
3.14
Beta
0.15
Beta1y
0.24
Beta2y
0.16
Ch YTD
-30.56
High
122.2
High52
275.8
High52 Date
2025-07-30
High52ch
-56.53%
Low
119.6
Low52
119.6
Low52 Date
2026-05-08
Low52ch
0.23%
Ma50ch
-12.63%
Price vs 200-day SMA
-34.09%
RSI
22.43
RSI Monthly
24.25
RSI Weekly
21.41
Sharpe ratio
-1.87x
Sortino ratio
-1.97
Total Return
3.26%
Tr YTD
-29.67
Tr15y
337.71%
Tr1m
-14.56%
Tr1w
-3.97%
Tr3m
-32.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
AUD 6B
Operating Income Growth
-2.1
Operating Income Growth Q
-3.16
Operating Income Growth3 Y
1.03
Operating Income Growth5 Y
3.26
Operating margin
26.08

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
485,008,433%
Net Borrowing
-1,351,537,600
Shares Insiders
0.06%
Shares Institutions
36.99%
Shares Out
485,318,955
Shares Qo Q
-0.05%
Shares Yo Y
0.1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

67
MetricValue
Adjusted FCF
AUD 4.3B
Average Volume
1,523,526.45x
Bv Per Share
58.02
CAPEX
AUD -830.6M
Ch10y
9.83
Ch15y
245.8
Ch1m
-14.56
Ch1w
-3.97
Ch1y
-50.66
Ch20y
510.4
Ch3m
-33.58
Ch3y
-60.18
Ch5y
-56.33
Ch6m
-33.04
Change
-1.74%
Change From Open
-1.37
Close
122
Days Gap
-0.38
Depreciation Amortization
1,133,636,640
Dollar Volume
236,000,083.7
Earnings Date
2026-08-18
EBIT
AUD 6B
EBITDA
AUD 7.3B
EPS
AUD 4.29
F Score
7
FCF
AUD 4.6B
FCF EV Yield
6.03x
FCF Per Share
AUD 9.42
Financing CF
-4,380,662,400
Fiscal Year End
June
Founded
1,916
Graham Number
78.31034
Graham Upside
-34.68
Income Tax
AUD 296.8M
Investing CF
-1,703,091,200
Is Primary Listing
1
Last Earnings Date
2026-02-11
Last Report Date
2025-12-31
Last Split Date
2007-10-18
Last Split Type
Forward
Lynch Fair Value
AUD 21.56
Lynch Upside
-82.01
Ma150
166.5
Ma150ch
-27.99%
Ma20
130.2
Ma20ch
-7.89%
Net CF
-568,196,800
Next Earnings Date
2026-08-18
Open
121.5
P FCF Ratio
12.72
P OCF Ratio
10.77
Payment Date
2026-04-09
Position In Range
10.47
Ppne
12,846,502,800
Price Date
2026-05-08
Price EBITDA
AUD 8.02
Ptbv Ratio
10.92
Relative Volume
1.35x
Revenue
23,098,174,400x
SBC By Revenue
0.99x
Share Based Comp
227,878,400
Tax By Revenue
1.29x
Tax Rate
12.66%
Tr20y
742.31%
Tr6m
-32.18%
Volume
1,968,636
Z Score
4.12
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

ASX/CSL dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+3.4%
$4.03 annual per share
Payout ratio
+101.5%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+8.6%
4 consecutive years of growth
Total shareholder yield
+3.3%
Next ex-dividend date: 2026-03-10
Performance

ASX/CSL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-49.4%
S&P 500 1Y: n/a
3Y total return
-58.0%
S&P 500 3Y: n/a
5Y total return
-52.9%
S&P 500 5Y: n/a
10Y total return
+26.0%
S&P 500 10Y: n/a
Ownership

Who owns ASX/CSL?

Insider, institutional, and short-interest positioning.

Institutional ownership
+37.0%
Share of float held by funds and institutions
Insider ownership
+0.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.1%
Negative means the company is buying back shares.
Technical

ASX/CSL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
22.4
Below 30: short-term oversold
Price vs 200-day MA
-34.1%
50/200-day relationship not available
Beta (5Y)
0.15
Less volatile than the market
Sharpe ratio
-1.87
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ASX/CSL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/CSL stock rating?

asx/CSL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/CSL analysis?

The full report lives at /stocks/asx/CSL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/CSL?

The latest report frames asx/CSL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/CSL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.